A Paradigm Change in Treatment

We’re dedicated to giving clinicians new and better ways to treat cancer with radiation therapy by combining the latest innovations in precision radiation delivery with groundbreaking MR image guidance and on-table adaptive therapy.

New Kind of Med Company R
0
MRIdian's installed globally

More Than

0
Patients

More Than

0
Disease sites treated*

The Team Behind ViewRay

ViewRay was founded on the belief that enhanced real-time visualization combined with online adapting and accurate dose recording will significantly improve the safety and efficacy of radiation therapy, leading to better outcomes for patients.

MRI-guided radiation therapy was conceived by company founder, James. F. Dempsey, PhD, while he was a member of the radiation oncology faculty at the University of Florida in 2004. Meet the team that helps bring MRIdian to life.

2004

Founded in Cleveland, Ohio

ViewRay was founded on the belief that enhanced real-time visualization combined with on-line adapting and accurate dose recording will significantly improve the safety and efficacy of radiation therapy, leading to better outcomes for patients.

2012

MRIdian 1st Generation FDA Clearance

The company strives to solve impossible problems to help clinicians better fight this deadly disease and to provide patients with new hope and a better quality of life. The result was the invention of the MRIdian MRI-guided radiation therapy technology. It is the first radiation therapy system that implements vision guided control by capturing real-time MRI images eight times a second, faster than human reaction time, to track the tumor as it moves and stop the radiation beam when the tumor moves out of position.

2014

First Patient Treated on MRIdian

ViewRay was founded on the belief that enhanced real-time visualization combined with on-line adapting and accurate dose recording will significantly improve the safety and efficacy of radiation therapy, leading to better outcomes for patients.

2016-2017

MRIdian 2nd Generation CE Mark & FDA Clearance

2021

MRIdian A3i System 510(k) Clearance

ViewRay annouced its next generation of MRI-guided radiation therapy features, focused on enhancing on-table adaptive workflow and expanding clinical utility. MRIdian A3i includes a suite of new features to streamline on-table adaptive workflow and provide the potential to reduce treatment times, along with a new brain treatment package expanding clinical utility into cranial stereotactic radiosurgery (SRS) and stereotactic radiation therapy (SRT)
Please fill out the form below to contact a ViewRay representative or sign up for email news updates.

General Inquiries
[email protected]

Media Inquiries
[email protected]

Investor Relations
[email protected]

Medical Affairs
[email protected]

Customer Service
855-286-8875

General Inquires
440-703-3210